Nicole Gabreski, Ph.D.
About Nicole Gabreski, Ph.D.
Nicole Gabreski, Ph.D., is the Vice President of Equity Research in Biotechnology at Piper Sandler, where she has worked since 2022. She holds a Ph.D. in Cellular and Molecular Biology from the University of Michigan and has over ten years of experience in biomedical research and equity analysis.
Current Role at Piper Sandler
Nicole Gabreski, Ph.D., serves as the Vice President of Equity Research in Biotechnology at Piper Sandler. She has held this position since 2022 and is based in Chicago, Illinois. In her role, she is responsible for providing insights and analysis on biotechnology companies, leveraging her extensive background in the field.
Previous Experience at Piper Sandler
Prior to her current role, Gabreski worked at Piper Sandler in various capacities. She served as an Equity Research Analyst in Biotechnology from 2019 to 2021 and as an Equity Research Associate from 2018 to 2019. She also held the position of Assistant Vice President for one year from 2021 to 2022. Her tenure at Piper Sandler spans over four years, during which she contributed to the firm's research efforts in the biotechnology sector.
Education and Expertise
Gabreski earned her Bachelor of Science degree in Biological Sciences and Animal Science from Cornell University, where she focused on Molecular and Cellular Biology. She continued her education at the University of Michigan, obtaining a Ph.D. in Cellular and Molecular Biology. Her academic background provides her with a strong foundation in genetics, biochemistry, and cellular biology.
Research Experience
Nicole Gabreski has over ten years of hands-on experience in biomedical research. She worked as a Graduate Student Research Assistant at the University of Michigan from 2011 to 2016, and as a Postdoctoral Research Fellow at Children's National Health System from 2016 to 2018. Her research experience includes a focus on translational and clinical research, enhancing her expertise in the biotechnology field.
Professional Development and Internships
Throughout her career, Gabreski has participated in various professional development opportunities. She was an Innovator-in-Residence Program Member at The SearchLite from 2014 to 2015 and completed a Genetics Internship in Clinical Pharmacogenomics at Merck in 2015. These experiences have contributed to her comprehensive understanding of the biotechnology landscape.